Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels.
α-Conotoxins are peptides from cone snails that target the nicotinic acetylcholine receptor (nAChR). RgIA and Vc1.1 have analgesic activity in animal pain models. Both peptides target the α9α10 nAChR and inhibit N-type calcium channels via GABA(B) receptor activation, but the mechanism of action of analgesic activity is unknown. PeIA has previously been shown to inhibit the α9α10 and α3β2 nAChRs. In this study, we have determined the structure of PeIA and shown that it is also a potent inhibitor of N-type calcium channels via GABA(B) receptor activation. The characteristic α-conotoxin fold is present in PeIA, but it has a different distribution of surface-exposed hydrophobic and charged residues compared with Vc1.1. Thus, the surface residue distribution, rather than the overall fold, appears to be responsible for the 50-fold increase in selectivity at the α3β2 nAChR by PeIA relative to Vc1.1. In contrast to their difference in potency at the nAChR, the equipotent activity of PeIA and Vc1.1 at the GABA(B) receptor suggests that the GABA(B) receptor is more tolerant to changes in surface residues than is the nAChR. The conserved Asp-Pro-Arg motif of Vc1.1 and RgIA, which is crucial for potency at the α9α10 nAChR, is not required for activity at GABA(B) receptor/N-type calcium channels because PeIA has a His-Pro-Ala motif in the equivalent position. This study shows that different structure-activity relationships are associated with the targeting of the GABA(B) receptor versus nAChRs. Furthermore, there is probably a much more diverse range of conotoxins that target the GABA(B) receptor than currently realized.
Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. n.daly@imb.uq.edu.au
Norelle L
NL
Daly
Brid
B
Callaghan
Richard J
RJ
Clark
Simon T
ST
Nevin
David J
DJ
Adams
David J
DJ
Craik
D020816:Amino Acid Motifs; D000818:Animals; D020864:Calcium Channels, N-Type / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D020916:Conotoxins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D009865:Oocytes; D018080:Receptors, GABA-B / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D013329:Structure-Activity Relationship; D014982:Xenopus laevis
D020864:Calcium Channels, N-Type; D020916:Conotoxins; D018080:Receptors, GABA-B; D011978:Receptors, Nicotinic; C507383:alpha-conotoxin Vc1.1
Channels (Austin). 2008 Mar-Apr;2(2):143-52
18849660
Biochem Pharmacol. 2009 Oct 1;78(7):693-702
19477168
Annu Rev Pharmacol Toxicol. 2007;47:699-729
17009926
Eur J Pharmacol. 2000 Mar 30;393(1-3):205-8
10771014
Pain. 2011 Feb;152(2):259-266
20889259
J Neurosci. 2008 Oct 22;28(43):10943-51
18945902
Expert Opin Ther Targets. 2007 Jul;11(7):891-7
17614758
J Biol Chem. 2005 Aug 26;280(34):30107-12
15983035
J Physiol. 1987 May;386:1-17
2445960
Channels (Austin). 2010 Jan-Feb;4(1):51-4
20368690
J Mol Biol. 2008 Apr 4;377(4):1216-27
18295795
Mol Pharmacol. 2007 Dec;72(6):1406-10
17804600
J Biol Chem. 2000 Nov 10;275(45):35335-44
10938268
Physiol Rev. 2009 Jan;89(1):73-120
19126755
Angew Chem Int Ed Engl. 2010 Sep 3;49(37):6545-8
20533477
Brain Res. 2005 Oct 19;1059(2):149-58
16182258
Biochemistry. 2006 Feb 7;45(5):1511-7
16445293
Curr Med Chem. 2001 Mar;8(4):327-44
11172693
Physiol Rev. 2004 Jan;84(1):41-68
14715910
Neuropsychopharmacology. 2009 Jan;34(1):244-6
19079069
J Physiol. 1993 Oct;470:1-11
8308719
Eur J Biochem. 2004 Jun;271(12):2320-6
15182347
J Physiol. 1992 Feb;447:391-407
1317434
Eur J Neurosci. 2000 Sep;12(9):3201-10
10998104
J Biol Chem. 2010 Apr 16;285(16):12355-66
20145249
J Biol Chem. 2009 Jul 24;284(30):20275-84
19447885
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17880-4
17101979
Curr Pharm Des. 2006;12(4):407-28
16472136
J Biol Chem. 2006 Aug 11;281(32):23254-63
16754662
J Biol Chem. 2009 Feb 20;284(8):4944-51
19098004
J Biomol NMR. 1995 Jan;5(1):67-81
7881273
Toxicon. 2006 Dec 1;48(7):810-29
16979678
Biochemistry. 1997 Sep 23;36(38):11323-30
9298951